Trial description:
A Phase II, open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma
Contact name:
Dr Fiona Harris
Trial start date:
Monday, January 21, 2019
Trial end date:
Friday, July 31, 2020
Trial tumour type:
Brain and CNS
Show on Radiotherapy:
No